What are the oral (PO) antibiotic options for a patient with an uncomplicated urinary tract infection (UTI) caused by Enterococcus faecalis, who is currently on Augmentin (amoxicillin-clavulanate), and has a urine culture showing sensitivity to ampicillin, levofloxacin, and vancomycin, but resistance to doxycycline and tetracycline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Antibiotic Options for Enterococcus faecalis UTI

Switch from Augmentin to oral amoxicillin 500 mg every 8 hours for 7 days, as this is the first-line treatment for ampicillin-sensitive E. faecalis UTI with proven efficacy. 1

Why Continue Beta-Lactam Therapy

  • Augmentin (amoxicillin-clavulanate) already contains the optimal drug (amoxicillin) for this infection, and since your culture shows ampicillin sensitivity, you can simplify to amoxicillin alone without the clavulanate component 1
  • Ampicillin/amoxicillin remains the drug of choice for enterococcal UTIs, achieving clinical eradication rates of 88.1% and microbiological eradication of 86% 1
  • The high urinary concentrations achieved by ampicillin can overcome even elevated MICs, making it highly effective for urinary tract infections 1

Alternative Oral Options Based on Your Sensitivities

Nitrofurantoin (Second Choice)

  • Nitrofurantoin 100 mg orally every 6 hours for 7 days is an effective alternative with resistance rates below 6% in E. faecalis 1
  • This is particularly useful if the patient has a penicillin allergy 1
  • Critical caveat: Do NOT use nitrofurantoin if this is a complicated UTI, pyelonephritis, or if creatinine clearance is <60 mL/min, as it achieves poor tissue concentrations and inadequate urinary levels in renal impairment 1

Fosfomycin (Third Choice)

  • Fosfomycin 3 g orally as a single dose is FDA-approved specifically for E. faecalis UTI 1, 2
  • Best reserved for uncomplicated cystitis only 1
  • Has minimal resistance and low propensity for collateral damage 3
  • May have slightly inferior efficacy compared to standard 7-day regimens 3

Why NOT to Use Levofloxacin Despite Sensitivity

  • Avoid fluoroquinolones (levofloxacin) even though your culture shows sensitivity because E. faecalis has high fluoroquinolone resistance rates of 46-47% in general populations 1
  • Fluoroquinolones should be reserved for more important indications and have an unfavorable risk-benefit ratio for uncomplicated UTIs 1
  • Multiple studies confirm 34-47% ciprofloxacin/levofloxacin resistance in E. faecalis from complicated UTIs 4, 5

Why Vancomycin is Not an Option

  • Vancomycin has no oral formulation that achieves adequate urinary concentrations for UTI treatment 3
  • It is reserved for IV use in serious systemic enterococcal infections like endocarditis or bacteremia 1

Treatment Duration and Monitoring

  • 7 days is the standard duration for uncomplicated E. faecalis UTI 1
  • Longer durations may be necessary if this is a complicated UTI (catheter-associated, anatomic abnormality, immunosuppression, or upper tract involvement) 1
  • Always confirm susceptibility testing even for "pansensitive" strains, as resistance patterns vary by institution 1

Common Pitfall to Avoid

  • Do not assume all enterococci are the same: E. faecium has much higher resistance rates (84.8% to ampicillin) compared to E. faecalis (4.8% to ampicillin), but your culture specifies E. faecalis, which is fortunately the more susceptible species 6
  • Cephalosporins (including those in some combination products) have NO activity against Enterococcus species due to natural resistance 1

References

Guideline

Treatment for Enterococcus faecalis in Urine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Bacterial resistance to antimicrobials in urinary isolates.

International journal of antimicrobial agents, 2004

Research

In vitro susceptibility of enterococci strains isolated from urine samples to fosfomycin and other antibiotics.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.